Market Value2,923,924,032
Total Holdings55
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SRZN / Surrozen, Inc.
UNH / UnitedHealth Group Incorporated
CAI / Caris Life Sciences, Inc.
BCAX / Bicara Therapeutics Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
BBNX / Beta Bionics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation
TRVI / Trevi Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
CGEM / Cullinan Therapeutics, Inc.
SKYE / Skye Bioscience, Inc.
AARD / Aardvark Therapeutics, Inc.
MTSR / Metsera, Inc.
GUARDANT HEALTH INC / DEBT 1.250% 2/1 (40131MAD1)
IMMUNOCORE HLDGS PLC / NOTE 2.500% 2/0 (45258DAB1)
IRHYTHM TECHNOLOGIES INC / NOTE 1.500% 9/0 (450056AB2)
KARYOPHARM THERAPEUTICS INC / NOTE 6.000% 5/1 (48576UAD8)
REPLIGEN CORP / NOTE 1.000%12/1 (759916AD1)
ATEC / Alphatec Holdings, Inc.
NUVL / Nuvalent, Inc.
TMDX / TransMedics Group, Inc.
EWTX / Edgewise Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
DHR / Danaher Corporation
ARGX / argenx SE - Depositary Receipt (Common Stock)
ADPT / Adaptive Biotechnologies Corporation
XNCR / Xencor, Inc.
NBIX / Neurocrine Biosciences, Inc.
US64049MAB63 / NeoGenomics Inc
XENE / Xenon Pharmaceuticals Inc.
US02081GAB86 / Alphatec Holdings, Inc.
PEN / Penumbra, Inc.
SYRE / Spyre Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
US46333XAH17 / CONV. NOTE
LUNG / Pulmonx Corporation
REPL / Replimune Group, Inc.
RGEN / Repligen Corporation
MRVI / Maravai LifeSciences Holdings, Inc.
TMO / Thermo Fisher Scientific Inc.
GH / Guardant Health, Inc.
CGON / CG Oncology, Inc.
VKTX / Viking Therapeutics, Inc.
CELC / Celcuity Inc.
HROW / Harrow, Inc.
ALGN / Align Technology, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
IRTC / iRhythm Technologies, Inc.
KIDS / OrthoPediatrics Corp.
ZURA / Zura Bio Limited
NVCR / NovoCure Limited
US252131AK39 / CONV. NOTE
INSP / Inspire Medical Systems, Inc.
KRYS / Krystal Biotech, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
ORKA / Oruka Therapeutics, Inc.
GMED / Globus Medical, Inc.
GKOS / Glaukos Corporation
KNSA / Kiniksa Pharmaceuticals, Ltd.
ISRG / Intuitive Surgical, Inc.
CSTL / Castle Biosciences, Inc.
SION / Sionna Therapeutics, Inc.
CBIO / Crescent Biopharma, Inc.